Secondary tumours in Sjogren's syndrome

作者：Kovacs Laszlo^*; Szodoray Peter; Kiss Emese

来源：Autoimmunity Reviews, 2010, 9(4): 203-206.

DOI：10.1016/j.autrev.2009.07.002

• Sjogren's syndrome
• Lymphoma
• Marginal zone B cell
• Activation-induced cytidin-deaminase
• B-lymphocyte activating factor
• Chemokine

The frequent association of Sjogren's syndrome (SS) with non-Hodgkin's B cell lymphoma (NHL) provides an example of the interplay of systemic autoimmunity and lymphoproliferative diseases, and an opportunity to study the pathogenetic steps of lymphomagenesis. NHL develops in approximately 5% of SS patients. Parotidomegaly, lymphadenopathy, inflammatory neuropathy and vasculitis have been found to be predictive of the development of lymphoma. A subsequent NHL is also heralded by the appearance of cryoglobulinaemia and serum or urinary monoclonal proteins. The typical histological type of NHL in SS is a low-grade extranodal marginal zone B cell lymphoma. The authors discuss the proposed key immunopathologic steps of lymphomagenesis in SS in detail. Recent results indicating the pathogenetic role of ectopic germinal centre formation in the involved exocrine glands, the potential importance of an antigen-driven clonal proliferation of autoreactive B-lymphocytes, the proposed role of the B-lymphocyte activating factor (BAFF) and of further cytokines and, finally, the changes of the chemokine milieu at the site of lymphoma development are highlighted.

• 出版日期2010-2